CD4 and glioblastoma: We recently observed similar findings where percentage of TIM-3 positivity on peripheral T cells (CD4+, CD8+, and Tregs) from glioblastoma patients were not significantly different to that seen on peripheral counterparts from age-matched healthy individuals [35].